Midjourney Pivots to Whole-Body Ultrasound Screening With $74M Investment, Drawing Radiologist Backlash

Generative AI firm Midjourney is investing over $74M to launch a whole-body ultrasound screening business — a move radiologists are publicly criticizing for lack of clinical evidence supporting its marketing claims.

• Midjourney, known for generative image AI, is entering direct-to-consumer or clinical ultrasound screening; no peer-reviewed clinical validation data appear to underpin the venture's stated claims.
• Radiologists on social media flagged the absence of evidence-based support for the company's marketing, raising concerns about patient safety and screening harms (false positives, incidentalomas, overdiagnosis).
• This is a trade-press news report — no independent clinical data, trial registration, or regulatory clearance details are cited in the source; claims should be treated as unverified until peer-reviewed evidence emerges.

RadPigeon summaries are original and for information only. They are not clinical advice.